IL152339A0 - Composition exhibiting enhanced formulation stability and delivery of topical active ingredients - Google Patents

Composition exhibiting enhanced formulation stability and delivery of topical active ingredients

Info

Publication number
IL152339A0
IL152339A0 IL15233901A IL15233901A IL152339A0 IL 152339 A0 IL152339 A0 IL 152339A0 IL 15233901 A IL15233901 A IL 15233901A IL 15233901 A IL15233901 A IL 15233901A IL 152339 A0 IL152339 A0 IL 152339A0
Authority
IL
Israel
Prior art keywords
delivery
active ingredients
composition exhibiting
formulation stability
exhibiting enhanced
Prior art date
Application number
IL15233901A
Other languages
English (en)
Original Assignee
Sol Gel Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Technologies Ltd filed Critical Sol Gel Technologies Ltd
Publication of IL152339A0 publication Critical patent/IL152339A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nanotechnology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Optics & Photonics (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
IL15233901A 2000-04-21 2001-04-20 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients IL152339A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19874900P 2000-04-21 2000-04-21
PCT/IL2001/000370 WO2001080823A2 (fr) 2000-04-21 2001-04-20 Composition a stabilite de preparation accrue et administration d'ingredients actifs topiques

Publications (1)

Publication Number Publication Date
IL152339A0 true IL152339A0 (en) 2003-05-29

Family

ID=22734655

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15233901A IL152339A0 (en) 2000-04-21 2001-04-20 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients

Country Status (9)

Country Link
EP (2) EP2324812A3 (fr)
JP (1) JP4979109B2 (fr)
AU (1) AU2001252513A1 (fr)
BR (1) BR0110600A (fr)
CA (1) CA2406008C (fr)
DE (1) DE10182378T1 (fr)
ES (1) ES2366886T1 (fr)
IL (1) IL152339A0 (fr)
WO (1) WO2001080823A2 (fr)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
JP2005512993A (ja) * 2001-11-08 2005-05-12 ゾル−ゲル テクノロジーズ エルティーディー． 水の比重より大きい比重を有する油状物を含有する組成物
GB0202853D0 (en) * 2002-02-07 2002-03-27 Dow Corning Encapsulation process and encapsulated compositions
GB2385789A (en) * 2002-02-25 2003-09-03 Celessence Internat Ltd Frangible, insect repellent containing microcapsules
DE50211883D1 (de) * 2002-04-30 2008-04-24 Cognis Ip Man Gmbh Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
US6669929B1 (en) 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
JP4800922B2 (ja) * 2003-01-24 2011-10-26 ザ リサーチ ファウンデイション オブ ステイト ユニバーシティー オブ ニューヨーク 光線力学療法用の治療薬を封入するためのセラミックベースナノ粒子及びその使用方法
US8071078B2 (en) 2003-02-26 2011-12-06 Basf Se Encapsulated colorants for natural skin appearance
US7923030B2 (en) 2003-03-14 2011-04-12 Sol-Gel Technologies, Inc. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
WO2005009604A1 (fr) 2003-07-31 2005-02-03 Sol-Gel Technologies Ltd. Microcapsules chargees d'ingredients actifs et procede de preparation
EP1727516B1 (fr) 2004-03-26 2014-05-14 DSM IP Assets B.V. Composition comprenant un inhibiteur d'hdac combine a un retinoide
GB2416524A (en) * 2004-07-24 2006-02-01 Dow Corning Microcapsules with siloxane walls formed in situ
MX2007009430A (es) * 2005-02-03 2007-08-17 Cinv Ag Materiales para suministro de farmacos producidos mediante la tecnologia de sol/gel.
KR101290853B1 (ko) * 2005-06-29 2013-07-29 디에스엠 아이피 어셋츠 비.브이. 선스크린제를 함유한 밀폐 캡슐을 갖는 조성물
AU2006273842B2 (en) 2005-07-28 2012-02-02 University Of Hull Topical formulations containing sporopollenin
CN101277757B (zh) * 2005-08-02 2011-11-30 索尔-格尔科技有限公司 非水溶性成分的金属氧化物涂布
US20080254082A1 (en) 2005-09-27 2008-10-16 Sol-Gel Technologies Ltd. Methods for Crop Protection
WO2008072239A2 (fr) 2006-12-12 2008-06-19 Sol-Gel Technologies Ltd. Formation de particules cœur-enveloppe nanométriques comportant une enveloppe d'oxyde métallique
KR101538295B1 (ko) 2006-12-28 2015-07-22 다우 코닝 코포레이션 다핵성 미세캡슐
KR101319367B1 (ko) 2007-01-03 2013-10-16 주식회사 엘지생활건강 피부 미백 패치 조성물
BRPI0808160A2 (pt) 2007-02-01 2014-09-23 Sol Gel Technologies Ltd Processo para revestir um material particulado sólido, insolúvel em água, com um óxido de metal, material particulado revestido, partículas, métodos para tratar uma condição de superfície em um indivíduo, e para prevenir, reduzir, ou eliminar pragas em um local, e, uso de material particulado revestido
KR20090125243A (ko) * 2007-02-01 2009-12-04 솔-겔 테크놀로지스 리미티드 퍼옥사이드 및 레티노이드를 함유하는 국소 도포용 조성물
US20090047222A1 (en) * 2007-08-15 2009-02-19 Ben Gu Color Stable Peroxide Containing Dentifrice Formulations With Dye Encapsulated Silica Shell Nanoparticles
GB0803538D0 (en) * 2008-02-27 2008-04-02 Dow Corning Deposition of lipophilic active material in surfactant containing compositions
GB0812513D0 (en) 2008-07-09 2008-08-13 Univ Hull Delivery vehicle
CN102112219A (zh) 2008-07-31 2011-06-29 溶胶凝胶技术公司 包含有效成分和金属氧化物壳的微胶囊,其制备方法及其用途
JP2012514593A (ja) 2009-01-05 2012-06-28 ゾル−ゲル テクノロジー リミテッド 被覆した活性剤を含む局所組成物
US9814657B2 (en) 2009-04-27 2017-11-14 Premier Dental Products Company Buffered microencapsulated compositions and methods
WO2010129309A2 (fr) 2009-04-27 2010-11-11 Premier Dental Products Compnay Compositions microencapsulées et procédés de minéralisation tissulaire
EP2449030A1 (fr) 2009-07-01 2012-05-09 Dow Corning Corporation Microcapsules contenant des siloxanes réticulables
US10653899B2 (en) 2009-12-31 2020-05-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
CN102596186B (zh) * 2009-12-31 2017-08-11 索尔-格尔科技有限公司 芯稳定的微胶囊、它们的制备方法以及它们的用途
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US9993019B2 (en) * 2010-03-26 2018-06-12 Philip Morris Usa Inc. Method for making particle of a hydrophobic additive and a polysaccharide coating and tobacco products containing particle of a hydrophobic additive and a polysaccharide coating
WO2011124706A1 (fr) * 2010-04-09 2011-10-13 Basf Se Encapsulation sol-gel in situ de fragrances, parfums ou agents aromatisants
WO2011154421A1 (fr) * 2010-06-09 2011-12-15 Basf Se Microcapsules contenant du principe actif et présentant une enveloppe qui contient de l'oxyde métallique
JP6050753B2 (ja) 2010-09-30 2016-12-21 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ ゾル−ゲルカプセルを処理する方法
EP2522331A1 (fr) 2011-05-09 2012-11-14 DSM IP Assets B.V. Utilisation de resvératrol et nicotinamide
EP2522328A1 (fr) 2011-05-09 2012-11-14 DSM IP Assets B.V. Utilisation de resvératrol et ascorbyl-2-glucoside
EP2522332A1 (fr) 2011-05-09 2012-11-14 DSM IP Assets B.V. Utilisation de resvératrol et phosphate à ascorbyl de magnésium
EP2522330A1 (fr) 2011-05-09 2012-11-14 DSM IP Assets B.V. Utilisation de resvératrol et extrait d'edelweiss
EP2522335A1 (fr) 2011-05-09 2012-11-14 DSM IP Assets B.V. Utilisation de resvératrol et phosphate à ascorbyl de sodium
EP2522329A1 (fr) 2011-05-09 2012-11-14 DSM IP Assets B.V. Utilisation de resvératrol et arbutine
BR112013031813A2 (pt) 2011-06-29 2016-12-13 Sol Gel Technologies Ltd composição para aplicação tópica
CN104039301A (zh) 2012-01-09 2014-09-10 帝斯曼知识产权资产管理有限公司 丹涅酮及其衍生物在皮肤护理中的用途
EP2623094A1 (fr) 2012-02-02 2013-08-07 DSM IP Assets B.V. Utilisation d'extrait d'edelweiss
CN102580106B (zh) * 2012-03-21 2013-07-10 浙江大学 一种pH敏感型聚电解质微囊给药载体的制备方法
ES2761202T3 (es) * 2012-05-22 2020-05-19 Dsm Ip Assets Bv Nanopartículas orgánicas-inorgánicas híbridas
EP2689836A1 (fr) 2012-07-26 2014-01-29 Basf Se Composition de microcapsules présentant une enveloppe de silice et un procédé pour leur préparation
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
CN108159425A (zh) * 2012-11-27 2018-06-15 索尔-格尔科技有限公司 用于治疗红斑痤疮的组合物
WO2014162311A1 (fr) 2013-04-01 2014-10-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Capsules réglables à base de sol-gel comprenant des fragrances, et des arômes et leurs utilisations
US20160067191A1 (en) 2013-04-18 2016-03-10 The Regents Of The University Of California Nanoscale coatings for encapsulation of biological entities
EP2848286A1 (fr) 2013-09-12 2015-03-18 DSM IP Assets B.V. Composition cosmétique comprenant de l'acide chicorique
EP2873414A1 (fr) 2013-11-19 2015-05-20 DSM IP Assets B.V. Utilisation d'un extrait d'edelweiss dans les soins capillaires pour la prévention de cheveux grisonnants
WO2015083836A1 (fr) 2013-12-06 2015-06-11 花王株式会社 Procédé de fabrication de microcapsules
US20170304169A1 (en) 2014-10-17 2017-10-26 Dsm Ip Assets B.V. Use of a cosmetic composition comprising 10-hydroxystearic acid
PL3659590T3 (pl) 2015-04-17 2022-04-04 The University Of Queensland Kompozycja, materiały cząsteczkowe i sposoby wytwarzania materiałów cząsteczkowych
EP3302717B1 (fr) 2015-06-04 2020-11-04 DSM IP Assets B.V. Utilisation cosmétique d'un extrait de gentiane sans gentiopicroside
EP3316974A1 (fr) 2015-06-30 2018-05-09 The Procter and Gamble Company Procédés de fabrication de compositions contenant plusieurs populations de microcapsules
CN107809994A (zh) 2015-06-30 2018-03-16 宝洁公司 包含多个微胶囊群体的组合物
CN105012173A (zh) * 2015-07-09 2015-11-04 常州艾瑞特电子有限公司 一种防治口腔溃疡的牙膏及其制备方法
WO2017029665A1 (fr) 2015-08-20 2017-02-23 Sol-Gel Technologies Ltd. Compositions pour application topique comprenant du peroxyde de benzoyle et de l'adapalène
JP6659019B2 (ja) * 2015-12-22 2020-03-04 花王株式会社 マイクロカプセル及びその製造方法
EP3299083A1 (fr) 2016-09-23 2018-03-28 Greenseal Research Ltd Matrices dérivées sol-gel personnalisées pour immobilisation chimique
CN110891561A (zh) 2017-07-12 2020-03-17 索尔-格尔科技有限公司 治疗痤疮的方法和组合物
WO2019012537A1 (fr) 2017-07-12 2019-01-17 Sol-Gel Technologies Ltd Compositions comprenant de la trétinoïne encapsulée
EP3713666B1 (fr) * 2017-11-23 2024-02-28 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Procédés de préparation de microcapsules
CN113195090B (zh) * 2018-10-16 2023-06-20 硅胶实验室制药公司 二氧化硅胶囊/球制备的可调方法及其用途
CN110192655B (zh) * 2019-04-28 2022-02-18 中国科学院上海药物研究所 一种α-生育酚的微球及其制备方法
GB202006988D0 (en) * 2020-05-12 2020-06-24 Cambrian Ventures Ltd Anti-viral preparation and method of manufacturing an antiviral preparation
CN112402271B (zh) * 2020-11-28 2022-05-03 科玛化妆品(北京)有限公司 一种类微胶囊前驱体及其制备方法
JP2023008936A (ja) 2021-06-30 2023-01-19 花王株式会社 マイクロカプセル水分散液

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957971A (en) 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
DE2642032C2 (de) 1976-09-18 1987-04-30 Rupprecht, Herbert, Prof. Dr., 8400 Regensburg Verfahren zur Inkorporierung von Wirkstoffen in siliciumdioxidhaltige Trägermaterialien und eine siliciumdioxidhaltige Zubereitung
US4880851A (en) 1987-02-26 1989-11-14 Tohru Yamamoto Aromatic composition and method for the production of the same
EP0309724B1 (fr) * 1987-10-01 1992-06-17 American Cyanamid Company Méthode pour la préparation d'esters dialcoyliques de l'acide dichlorosuccinique
IL93134A (en) * 1990-01-23 1997-11-20 Yissum Res Dev Co Doped sol-gel glasses for obtaining chemical interactions
US5520917A (en) * 1992-07-27 1996-05-28 Suzuki Yushi Industries Co., Ltd. Materials in the form of colored spherical fine particles
US5846554A (en) 1993-11-15 1998-12-08 Zeneca Limited Microcapsules containing suspensions of biologically active compounds and ultraviolet protectant
DE4341113B4 (de) 1993-12-02 2006-04-13 IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG Stabile multiple X/O/Y-Emulsion
US5591453A (en) 1994-07-27 1997-01-07 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US5851538A (en) 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
US5874105A (en) 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
EP1618896A3 (fr) 1996-05-29 2010-07-14 DelSiTech Oy Xerogel de silice pour applications biologiques
IL120022A (en) * 1997-01-16 2003-02-12 Yissum Res Dev Co Sunscreens for protection from sun radiation
ES2216360T3 (es) * 1998-02-06 2004-10-16 Seiwa Kasei Co., Ltd. Microcapsula con pared particular y su procedimiento de fabricacion.
FR2774906B1 (fr) * 1998-02-13 2000-05-12 Rhodia Chimie Sa Systeme d'encapsulation a coeur organique et a ecorce minerale a base d'hydroxycarbonate d'aluminium et son procede de preparation
DE19811900C2 (de) 1998-03-18 2003-12-11 Kallies Feinchemie Ag Biokompatibles Kompositmaterial, Verfahren zu seiner Herstellung und seine Verwendung
US6146664A (en) 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
US6103267A (en) 1998-07-27 2000-08-15 Sunsmart, Inc. Stabilized ascorbic acid, composition, and method of use
ES2382536T3 (es) * 1998-08-13 2012-06-11 Sol-Gel Technologies Ltd. Procedimiento de preparación de microcápsulas de óxido cargadas con moléculas funcionales y productos obtenidos a partir de las mismas
FR2785292B1 (fr) * 1998-10-30 2002-06-28 Rhodia Chimie Sa Capsules a ecorce minerale poreuse dans lesquelles sont immobilisees dans un milieu biologique liquide, une ou plusieurs matieres biologiques, leurs procede de preparation et utilisations
US6238650B1 (en) * 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6395299B1 (en) 1999-02-12 2002-05-28 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
ES2283300T3 (es) * 1999-05-25 2007-11-01 Sol-Gel Technologies Ltd. Un procedimiento para obtener composiciones de filtros solares fotoestables.

Also Published As

Publication number Publication date
JP2003534249A (ja) 2003-11-18
WO2001080823A2 (fr) 2001-11-01
ES2366886T1 (es) 2011-10-26
EP1335693A2 (fr) 2003-08-20
JP4979109B2 (ja) 2012-07-18
WO2001080823A3 (fr) 2003-05-30
EP2324812A3 (fr) 2012-09-19
EP2324812A2 (fr) 2011-05-25
CA2406008A1 (fr) 2001-11-01
BR0110600A (pt) 2003-04-15
AU2001252513A1 (en) 2001-11-07
DE10182378T1 (de) 2012-02-02
CA2406008C (fr) 2011-03-15

Similar Documents

Publication Publication Date Title
IL152339A0 (en) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
AU2002343191A1 (en) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
HUP0401984A3 (en) Use of type 4 phosphodiesterase inhibitors for preparation of pharmaceutical compositions and combination with other active ingredients
HUP0400240A3 (en) Combinations of substituted oxazolidinones and other active ingredients and pharmaceutical compositions containing them
HUP0302508A3 (en) Pyridazinones and triazinones and their use as active ingredients of pharmaceutical compositions
HUP9903216A3 (en) Substituted benzamide and use of them as active ingredient in pharmaceutical compositions
AU3104301A (en) Compositions and methods to effect the release profile in the transdermal administration of active agents
MY129406A (en) Taste masked liquid pharmaceutical compositions
EP1233756A4 (fr) Excipients solides pour administration amelioree d'ingredients actifs contenus dans des compositions pharmaceutiques
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
HUP0402497A3 (en) Pharmaceutical compositions containing two activ ingredients and their uses
HUP0301452A3 (en) Pharmaceutical composition containing photochemotherapeutic agent and mucoadhesive agent and its use
EE04965B1 (et) Imidasoimidasoolid ja triasoolid kui p?letikuvastased hendid, nende kasutamine ravimite valmistamiseks ning farmatseutiline kompositsioon
AU2001236457A1 (en) Compounds and compositions for delivering active agents
HUP0300263A3 (en) Anthranilamides derivatives, their use and arthropodicide compositions containing them as active ingredient
AU2001284985A1 (en) Compounds and compositions for delivering active agents
AU5905400A (en) Methods and compositions for delivery and retention of active agents to lymph nodes
HUP0300653A3 (en) Liquid composition formulations, containing herbicidal active ingredients preparing and use thereof
AU2001288277A1 (en) Compounds and compositions for delivering active agents
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
AU2001222986A1 (en) Dehydroascorbic acid formulations and uses thereof
AU2002215944A1 (en) Film for active ingredients dermal and transdermal administration
PL362965A1 (en) Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
AU2001278516A1 (en) Oral cosmetic composition comprising petroleum jelly enrobing an active agent
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions